WA
Therapeutic Areas
Orion Integrated Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| RIGEL Biodefense Analytical Enterprise | Biothreat Detection & Characterization | Development/Deployment |
| Host Infection Biomarker Discovery | Early Infection Detection | Research |
| Rational Combinational Antimicrobial Development | Antimicrobial Resistance | Research |